SS-31 (Elamipretide)
Human observationalAlso known as: Elamipretide, MTP-131
Community-reported ranges are anecdotal and not clinically validated. Evidence grade shown reflects the strength of available human data. Not a prescription. Legal status varies by country and changes over time; verify locally.
Overview
A mitochondria-targeting peptide in clinical development for mitochondrial and cardiac disease. Investigational; not approved.
Mechanism
Binds cardiolipin in the inner mitochondrial membrane, aiming to stabilise energy production.
Evidence
Clinical trials conducted with mixed results; investigational, not approved.
Community-reported information
Investigational; used outside trials anecdotally. General information only.
General information only, not tailored to you and not a recommendation. Some regions withhold this entirely.
Half-life
Short.
Storage
Refrigerate.
Commonly reported side effects
- Injection-site reactions
- Generally tolerated in trials
Legal status by region
- USInvestigational; not FDA-approved.
Legal status changes over time; verify locally before relying on this.